RUBY - Rubius Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - RUBY (1709401)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-02-24
RUBYAppelhans DannielleCEO, PresS - Sale$0.13-10,3850-100%-$1,323
2023-02-01
RUBYCagnoni Pablo JDirS - Sale$0.25-8,44866,082-11%-$2,112
D
2023-02-01
RUBYAppelhans DannielleCEO, PresS - Sale+OE$0.25-3,87810,385-27%-$970
D
2023-01-31
RUBYCagnoni Pablo JDirS - Sale+OE$0.24-7,24074,530-9%-$1,745
D
2023-01-31
RUBYTurka Laurence A.Chief Scientific OfficerS - Sale+OE$0.24-2,59318,391-12%-$622
D
2022-08-10
RUBYAppelhans DannielleCOOS - Sale+OE$0.80-5,7376,763-46%-$4,590
2022-04-21
RUBYEpstein David RDirP - Purchase$1.44+30,0004,720,012+1%+$43,329

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top